Table 1.
Baseline Demographics and Outcomes in All Patients with a TTE Conducted during Admission.
| Characteristic | N | N = 4271 |
|---|---|---|
| Age | 427 | 61.87 (15.03) |
| Sex | 427 | |
| Male | 243 / 427 (57%) | |
| Female | 184 / 427 (43%) | |
| Atrial fibrillation | 421 | 136 / 421 (32%) |
| (Missing) | 6 | |
| CAD | 421 | 183 / 421 (43%) |
| (Missing) | 6 | |
| HTN | 421 | 321 / 421 (76%) |
| (Missing) | 6 | |
| Valvular disease | 421 | 138 / 421 (33%) |
| (Missing) | 6 | |
| CHF | 425 | 81 / 425 (19%) |
| (Missing) | 2 | |
| CKD | 425 | 122 / 425 (29%) |
| (Missing) | 2 | |
| CKD on dialysis | 421 | 82 / 421 (19%) |
| (Missing) | 6 | |
| COPD | 421 | 46 / 421 (11%) |
| (Missing) | 6 | |
| DM | 421 | 238 / 421 (57%) |
| (Missing) | 6 | |
| HLD | 421 | 251 / 421 (60%) |
| (Missing) | 6 | |
| Asthma | 421 | 53 / 421 (13%) |
| (Missing) | 6 | |
| Cancer | 421 | 56 / 421 (13%) |
| (Missing) | 6 | |
| Stroke | 421 | 95 / 421 (23%) |
| (Missing) | 6 | |
| Pacemaker or ICD | 421 | 19 / 421 (4.5%) |
| (Missing) | 6 | |
| RV size | 309 | 38.66 (9.10) |
| (Missing) | 118 | |
| TASPE | 268 | 19.75 (5.46) |
| (Missing) | 159 | |
| Elevated PA pressure | 260 | |
| Normal | 150 / 260 (58%) | |
| Elevated | 110 / 260 (42%) | |
| (Missing) | 167 | |
| PASP (measured) | 192 | 38.58 (15.11) |
| (Missing) | 235 | |
| RAP | 187 | 8.00 (3.00, 15.00) |
| (Missing) | 240 | |
| Dilated RV cavity | 427 | |
| Normal | 360 / 427 (84%) | |
| Dilated | 67 / 427 (16%) | |
| LVEF | 421 | 57.58 (11.56) |
| (Missing) | 6 | |
| LVEDD | 278 | 45.11 (7.74) |
| (Missing) | 149 | |
| Pericardial effusion (%) | 420 | |
| Absent | 416 / 420 (99%) | |
| Present | 4 / 420 (1.0%) | |
| (Missing) | 7 | |
| RV function (Abnormal S' or TAPSE or abnormal by visual estimation. Definition: TAPSE < 17 mm or S’ < 9.5 cm/s) | 386 | |
| Normal | 220 / 386 (57%) | |
| Abnormal | 166 / 386 (43%) | |
| (Missing) | 41 | |
| LVEDD (Definition: LVEDD > 58.4 mm (male) or > 52.2 mm (female)) | 278 | |
| Normal | 256 / 278 (92%) | |
| Abnormal | 22 / 278 (7.9%) | |
| (Missing) | 149 | |
| LVEF (Definition: LVEF < 50%) | 421 | |
| Normal | 349 / 421 (83%) | |
| Abnormal | 72 / 421 (17%) | |
| (Missing) | 6 | |
| RV size (Definition: RV basal diameter > 41 mm) | 309 | |
| Normal | 203 / 309 (66%) | |
| Abnormal | 106 / 309 (34%) | |
| (Missing) | 118 | |
| RV by visual estimation | 378 | |
| Normal | 302 / 378 (80%) | |
| Abnormal | 76 / 378 (20%) | |
| (Missing) | 49 | |
| Wall motion abnormalities | 404 | 56 / 404 (14%) |
| (Missing) | 23 | |
| Takotsubo or stress cardiomyopathy | 406 | 6 / 406 (1.5%) |
| (Missing) | 21 | |
| Composite outcome: Invasive ventilation, death at 60d, shock, thromboembolism or need for RRT | 427 | 249 / 427 (58%) |
| Death at 60 days | 427 | 109 / 427 (26%) |
| Invasive ventilation | 427 | 207 / 427 (48%) |
| RRT | 427 | 85 / 427 (20%) |
| Shock | 427 | 181 / 427 (42%) |
| Thromboembolic event | 427 | 42 / 427 (9.8%) |
| 1Median (p25, p75), mean (sd) or Frequency (%) | ||
Abbreviations: CAD, coronary artery disease; HTN, hypertension; CHF, congestive heart failure; CKD, chronic kidney disease; COPD, chronic obstructive pulmonary disease; DM, diabetes mellitus; HLD, hyperlipidemia; ICD, implantable cardioverter defibrillator; RV, right ventricular; TAPSE, tricuspid annular plane systolic excursion; PA, pulmonary artery; PASP, pulmonary artery systolic pressure; RAP, right atrial pressure; LVEF, left ventricular ejection fraction; LVEDD, left ventricular end diastolic diameter; S’, peak lateral tricuspid annular systolic velocity; RRT, renal replacement therapy.